ELRIG Drug Discovery 2026 has ended. This guide stays up as the record of who was there. Next: ELRIG DD 2027, Oct 19–20, 2027 in Liverpool

AI and machine learning at ELRIG Drug Discovery 2026

Oct 14–15, 2026 London, UK ~3k attendees Website

58 organizations at ELRIG Drug Discovery 2026 present work in AI, machine learning and lab-in-the-loop: 47 technology and service providers, 7 drug developers and 4 academic, government and non-profit bodies. Between them they bring 48 presentations to the program. Most represented: AstraZeneca (11 on the program), GSK (8 on the program), Pharmaron (3 on the program). As of Oct 8, 2026.

All 388 organizations at ELRIG Drug Discovery 2026 →

Showing 1–10 of 58 organizations

Organization	ELRIG Drug Discovery 2026 Attendance
AstraZeneca Cambridge, UK	◆Partner
astrazeneca.com Large pharmaPartner Global biopharmaceutical company discovering and developing medicines in oncology, rare disease, and cardiovascular, renal, metabolic and respiratory disease.	Booth Exhibiting at Booth CZ01 Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm Chair Wed Oct 14 11:15am–11:20am Track Chair - CRISPR/Cas technologies from discovery to therapeutic application How CRISPR gene editing is used from finding drug targets to engineering cell and gene therapies, and where it may go next. Tech Theatre with The Francis Crick Institute Chair Wed Oct 14 11:15am–11:20am Track Chair - Next-gen biophysics How biophysics has shaped drug discovery from checking targets to refining lead compounds, and how newer methods can speed programmes up. Auditorium 4 with Domainex Talk Wed Oct 14 11:20am–11:50am From Design Space to Data Space: An AI-Driven Approach to Better Cell Models and Smarter Assays Auditorium 2 Integrating experimental design, lab-in-the-loop and AI towards translatable discovery Talk Wed Oct 14 11:50am–12:20pm Automating In Vivo Antibody Discovery How a manual B-cell processing workflow was automated to reduce operator variability and raise throughput while preserving cell quality. Exhibition Hall Theatre with Hamilton Talk Wed Oct 14 12:20pm–12:50pm Finding Small Molecule Tools in Compound Pools using Surface Plasmon Resonance Auditorium 4 Next-gen biophysics Talk Wed Oct 14 2:40pm–3:10pm Transforming Targeted Therapeutics: Innovation in ADC Bioconjugation and Radioligands Auditorium 3 Targeted potency: Advances in radioligands and bioconjugates Talk Wed Oct 14 3:10pm–3:45pm To PhD or not to PhD? Navigating Life Sciences careers as an ECP Whether early career scientists gain more from a doctorate or from hands-on experience, and how people actually build life science careers. Learning Zone Panel Wed Oct 14 4:30pm–5:00pm Panel session - The Future of AI and Design of Experiments in Drug Discovery Auditorium 2 Integrating experimental design, lab-in-the-loop and AI towards translatable discovery · with Cambridge Consultants, IQVIA Talk Wed Oct 14 4:30pm–5:00pm Rewriting Disease-Causing Variants: Templated Editing In Vivo Tech Theatre CRISPR/Cas technologies from discovery to therapeutic application Talk Thu Oct 15 12:40pm–1:10pm The AstraZeneca Global Cell Bank: Powering Consistent and Compliant Drug Discovery Auditorium 4 From sample to translation: Solving the practical challenges of modern drug discovery Talk Thu Oct 15 3:30pm–4:00pm (AI)straZeneca: Case Studies in the Integration of Machine Learning and Medicinal Chemistry Auditorium 3 AI in medicinal chemistry
GSK London, UK	◆Partner
gsk.com Large pharmaPartner Global biopharmaceutical company developing vaccines and specialty medicines in infectious disease, HIV, respiratory, immunology and oncology.	Booth Exhibiting at Booth CZ02 Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm Chair Wed Oct 14 11:15am–11:20am Track Chair - Engineering the cell microenvironment: Cell-based models for drug discovery How engineered cell surroundings, from three-dimensional cultures to immune-competent models, help lab assays better predict what happens in patients. Auditorium 1 with Nottingham Trent University Talk Wed Oct 14 11:20am–11:50am Biophysics: A Look Back at Changing Tools and Changing Questions Auditorium 4 Next-gen biophysics Talk Wed Oct 14 2:00pm–2:30pm Designing Smarter Experiments: Connecting DoE, Laboratory Automation and AI in a Translational Discovery Workflow Auditorium 2 Integrating experimental design, lab-in-the-loop and AI towards translatable discovery Talk Wed Oct 14 2:00pm–2:30pm Sarcoma patient derived 3D cell culture models for drug discovery and prediction of the clinical trials outcome Auditorium 1 Engineering the cell microenvironment: Cell-based models for drug discovery Talk Wed Oct 14 2:40pm–3:10pm Patient-Derived Intestinal Organoids: Advancing Gut Complexity for Drug Discovery and Development Auditorium 1 Engineering the cell microenvironment: Cell-based models for drug discovery Talk Wed Oct 14 5:30pm–6:30pm Early Career Professionals: Network Like A Boss Meeting other early career professionals in speed networking rounds to build the contacts a drug discovery career depends on. Learning Zone with Liverpool School of Tropical Medicine Panel Thu Oct 15 9:30am–10:15am Keynote Panel - 20 Years of Discovery: Lessons from the Past, Blueprints for the Next 20 What two decades of change in drug discovery, from high-throughput screening to AI design, teach about building the next generation of medicines. Auditorium 1 with Constructive Bio, Omega Funds, OtoImmune +1 more Talk Thu Oct 15 2:30pm–3:00pm Automated Molecular Design in BRADSHAW: Application to GSK Projects Auditorium 3 AI in medicinal chemistry
Pharmaron Beijing, China	◆Conference Partner
pharmaron.com CROs & CDMOsConference Partner Contract research, development and manufacturing provider covering small molecules, biologics and cell and gene therapy, with integrated discovery teams from hit to candidate.	Booth Exhibiting at Booth D12, D13 Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm Chair Thu Oct 15 10:50am–10:55am Track Chair - AI in medicinal chemistry How AI and machine learning are changing drug discovery, covering compound quality, links to lab validation and newer AI tools. Auditorium 3 with IUPAC, Royal Society of Chemistry Talk Thu Oct 15 11:25am–11:55am A CNS‑Focused Approach to Selective PARP1 Drug Discovery How chemists designed a selective, brain-penetrant oral inhibitor for brain cancers, aiming to avoid the blood toxicities that limit older drugs. Exhibition Hall Theatre
Ignota Labs Cambridge, UK
ignotalabs.ai Biotech AI company rescuing failed or shelved drug candidates by solving safety problems and creating new chemistry and IP.	Talk Thu Oct 15 12:40pm–1:10pm Giving failed drugs a second chance with AI Auditorium 3 AI in medicinal chemistry Panel Thu Oct 15 3:30pm–4:00pm Panel session - Beyond the Pitch: Navigating the Highs and Lows of Entrepreneurship Breakthrough Zone Breakthrough Zone - Bridging the critical gap between discovery and successful commercialisation · with Creasallis, MFX
IQVIA Durham, NC
iqvia.com CROs & CDMOs Clinical research and health data company whose laboratories business runs drug discovery biology, DMPK and translational assay work for clients.	Talk Wed Oct 14 12:20pm–12:50pm Optimising and Miniaturising Translational Assays to Enable AI-Driven Drug Discovery, Harnessing Modern Laboratory Automation and Design of Experiments Auditorium 2 Integrating experimental design, lab-in-the-loop and AI towards translatable discovery Panel Wed Oct 14 4:30pm–5:00pm Panel session - The Future of AI and Design of Experiments in Drug Discovery Auditorium 2 Integrating experimental design, lab-in-the-loop and AI towards translatable discovery · with AstraZeneca, Cambridge Consultants
University of Edinburgh Edinburgh, UK
ed.ac.uk Academic & healthcare Public research university in Edinburgh, Scotland.	Talk Wed Oct 14 2:00pm–2:30pm Intratarget Microdosing in the human lung to accelerate therapeutic development Exhibition Hall Theatre Translating ideas into therapies - Navigating the challenges Talk Thu Oct 15 3:00pm–3:30pm Deep Machine Learning on Chemical Synthesis Auditorium 3 AI in medicinal chemistry
Axxam Milan, Italy	◆Conference Partner
axxam.com CROs & CDMOsConference Partner Contract research organisation offering integrated early discovery, from AI-supported target identification and validation through hit finding to hit-to-lead, with compound collections.	Booth Exhibiting at Booth G06, G07 Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm Talk Thu Oct 15 11:25am–11:55am From Gene Perturbation to Phenotype: Integrating Cell Painting and Transcriptomics in Human iPSC-Derived Motor Neurons Auditorium 2 The power of imaging in drug discovery and the clinic
Carterra Salt Lake City, Utah	◆Conference Partner
carterra-bio.com Instruments & automationConference Partner Makes high-throughput SPR platforms (LSA, LSA-XT, Ultra, Vega) for label-free screening and characterisation of large and small molecules.	Booth Exhibiting at Booth G08 Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm Talk Wed Oct 14 11:50am–12:20pm HT-SPR Technology as a Data Engine for AI-Driven Drug Design How high-throughput surface plasmon resonance binding measurements can generate the large, consistent datasets that train AI models for drug design. Auditorium 4
CAS Columbus, Ohio
cas.org Software & AI Division of the American Chemical Society curating a large body of scientific data and offering knowledge-management and AI solutions to research organisations.	Booth Exhibiting at Booth K17 Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm Talk Thu Oct 15 11:55am–12:10pm Flash Poster Presentation - Combining human-curated data and machine learning to accelerate drug discovery Auditorium 3 AI in medicinal chemistry
Cenevo	◆Conference Partner
cenevo.com Software & AIConference Partner Lab software combining Mosaic sample management with Labguru inventory, registration, ELN and LIMS, plus automation, orchestration and AI tools.	Booth Exhibiting at Booth D03 Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm Talk Thu Oct 15 11:25am–11:55am Rethinking Sample Management in the Age of AI How lab sample management systems must change so AI agents can query sample data and start work across connected lab tools. Auditorium 3